Skip to main content

Dr. Albert Chin Featured on Innovators' Journey to Discuss Medical Innovations





SAN FRANCISCO, CA, January 27, 2026 /24-7PressRelease/ -- Dr. Albert Chin was featured on Innovators' Journey to discuss his work on advancing minimally invasive approaches for cardiovascular procedures. Dr. Chin is the chief innovation officer and co-founder of multiple medical companies, including Orare Medsystems, PercAssist and FemDX Medsystems. He has over 238 issued US patents and developed multiple medical technology products throughout his career. Dr. Chin's inventions have played a vital role in many medical procedures and have contributed to saving lives. One of his most notable creations is a device for cardiac support without open-heart surgery, utilizing a minimally invasive approach. Dr. Chin attributes his success in the medical field to his commitment to continuous learning.

Watch the segment here.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.54
+3.12 (1.31%)
AAPL  260.86
+5.45 (2.13%)
AMD  253.54
+2.23 (0.89%)
BAC  52.01
-0.01 (-0.02%)
GOOG  337.09
+3.50 (1.05%)
META  671.60
-0.76 (-0.11%)
MSFT  478.47
+8.19 (1.74%)
NVDA  189.57
+3.10 (1.67%)
ORCL  177.68
-4.76 (-2.61%)
TSLA  434.34
-0.86 (-0.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.